RhumbLine Advisers
HPTX

RhumbLine Advisers’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

RhumbLine Advisers’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,513
Closed -$666K – 3191
2015
Q1 		$666K Buy
14,513
+2,400
+20% +$71.8K ﹤0.01% 2115
2014
Q4 		$291K Buy
12,113
+200
+2% +$4.51K ﹤0.01% 2606
2014
Q3 		$300K Sell
11,913
-140
-1% -$3.48K ﹤0.01% 2518
2014
Q2 		$315K Buy
+12,053
New +$310K ﹤0.01% 2573

RhumbLine Advisers's HPTX Position: Q2 2015 in Review

RhumbLine Advisers sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 14,513 shares — an estimated $666K sold.

RhumbLine Advisers first reported a position in HPTX in Q2 2014 and held it in 4 quarters. The position peaked at $666K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • RhumbLine Advisers reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • RhumbLine Advisers sold 14,513 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $666K.
  • RhumbLine Advisers first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • RhumbLine Advisers's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $666K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on RhumbLine Advisers's 13F filing for Q2 2015, filed 4 Aug 2015.